Assenagon Asset Management S.A. / GILD
Assenagon Asset Management S.A.’s Gilead Sciences Inc Position
Does Assenagon Asset Management S.A. own Gilead Sciences Inc (GILD)? Yes — 2.29M shares worth $289M (+0.36% of its 13F portfolio) as of Q2 2026, up from 512.4K shares the prior filed quarter.
Position Value
$289M
Q2 2026
Shares
2.29M
% of Portfolio
+0.36%
Quarters Held
31
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 2.29M | $289M | +0.36% |
| Q1 2026 | 512.4K | $71M | +0.11% |
| Q4 2025 | 267.1K | $33M | +0.05% |
| Q3 2025 | 3.49M | $387M | +0.53% |
| Q2 2025 | 1.32M | $146M | +0.22% |
| Q1 2025 | 361.6K | $41M | +0.07% |
| Q4 2024 | 585.1K | $54M | +0.09% |
| Q3 2024 | 2.34M | $196M | +0.36% |
| Q2 2024 | 899.9K | $62M | +0.14% |
| Q1 2024 | 1.51M | $111M | +0.26% |
| Q4 2023 | 314.8K | $25M | +0.07% |
| Q3 2023 | 632.7K | $47M | +0.15% |
| Q2 2023 | 324.9K | $25M | +0.09% |
| Q1 2023 | 751.2K | $62M | +0.22% |
| Q4 2022 | 783.0K | $67M | +0.24% |
| Q3 2022 | 1.68M | $104M | +0.40% |
| Q2 2022 | 418.4K | $26M | +0.10% |
| Q1 2022 | 846.1K | $50M | +0.14% |
| Q4 2021 | 1.08M | $79M | +0.23% |
| Q3 2021 | 933.2K | $65M | +0.21% |
| Q2 2021 | 29.8K | $2M | +0.01% |
| Q1 2021 | 257.0K | $17M | +0.07% |
| Q4 2020 | 818.8K | $48M | +0.21% |
| Q3 2020 | 19.1K | $1M | +0.01% |
| Q2 2020 | 38.8K | $3M | +0.02% |
| Q1 2020 | 336.6K | $25M | +0.20% |
| Q4 2019 | 1.20M | $78M | +0.49% |
| Q3 2019 | 640.9K | $41M | +0.27% |
| Q2 2019 | 842.0K | $57M | +0.43% |
| Q1 2019 | 173.0K | $11M | +0.11% |
| Q4 2018 | 774.1K | $48M | +0.55% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of GILD.